Stock listing
Aquis:EUKM Eukedos SpA Share Price
UK listing (Aquis) of Eukedos SpA · home listing Milan:EUK
Follow Eukedos SpA into a list and get an email when it puts out news.
Home listing price · MIL:EUK
€0.47 EUR -0.03 (-6.0%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, MIL:EUK · Price from Euronext
- Day range
- €0.47 – €0.48 EURNov 20, 2026
- Volume
- 7,853 sharesNov 20, 2026
- Market cap
- €10.69M EURAt the close on Nov 20, 2026 · price × 22.74M shares outstanding

Daily closes
Last 3 months, Oct 27, 2026 – Nov 20, 2026 · MIL:EUK · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.47 | -0.03 | -6.0% | €0.48 | €0.48 | €0.47 | 7,853 | |
| €0.50 | +0.022 | +4.6% | €0.48 | €0.50 | €0.48 | 144 | |
| €0.478 | -0.002 | -0.4% | €0.48 | €0.48 | €0.478 | 276 | |
| €0.48 | 0.00 | 0.0% | €0.50 | €0.50 | €0.48 | 55 | |
| €0.48 | -0.025 | -5.0% | €0.48 | €0.48 | €0.48 | 99 | |
| €0.505 | -0.005 | -1.0% | €0.535 | €0.535 | €0.505 | 540 | |
| €0.51 | +0.012 | +2.4% | €0.48 | €0.51 | €0.48 | 163 | |
| €0.498 | +0.02 | +4.2% | €0.48 | €0.498 | €0.478 | 165 | |
| €0.478 | -0.002 | -0.4% | €0.478 | €0.478 | €0.478 | 922 | |
| €0.48 | — | — | €0.48 | €0.48 | €0.48 | 160 |
- Ticker
- Aquis:EUKM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- Aquis
- Currency
- EUR
What changed lately
Latest news release · Mar 30, 2026
Eukedos FY Net Loss EUR 0.7 Mln
Latest news
Eukedos SpA on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 1 in the last 12 months · 2 in all · newest Mar 30, 2026 · oldest 2025
- Decks
- 1 deck · latest Jun 20, 2013
Where Eukedos SpA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Milan:EUK · Home listing | Milan | Italy | EUR |
| LSE:0Q8E | LSE | United Kingdom | EUR |
| Aquis:EUKM · This page | Aquis | United Kingdom | EUR |
| Aquis:EUKM | Aquis | United Kingdom | EUR |
| Turquoise:EUKM | Turquoise | United Kingdom | EUR |
Valuation
EV/sales 0.2× against a median of 1.6×: the lowest of 11 Health care services companies shown. Statements: Year to Dec 31, 2025 · price Nov 20, 2026
- Enterprise value
- €10.27M EUR
- P/E
- Loss
- EV/sales
- 0.2×
- EV/EBITDA
- 1.2×
- Price/book
- 0.4×
- Gross margin
- 21.1%
- Operating margin
- 10.2%
- Net margin
- −1.4%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Eukedos SpA · MIL:EUK | US$11.73M | US$11.27M | n/a | 0.2× | 1.2× | 0.4× | −1.4% | 0.0× | n/a |
| Beamtree Holdings Ltd · ASX:BMT | US$12.71M | US$13.72M | n/a | 0.7× | 149× | 0.8× | −62.6% | 0.2× | n/a |
| Genesis Fertility Center Public Company Limited · SET:GFC | US$12.70M | US$9.80M | 19.3× | 0.9× | 4.0× | 0.8× | 6.3% | 0.0× | n/a |
| Talius Group Limited · ASX:TAL | US$12.55M | US$9.78M | n/a | 1.9× | n/a | 3.1× | −19.1% | 0.1× | n/a |
| Mukdahan International Hospital Public Company Limited · SET:HANN | US$12.20M | US$9.07M | 66.8× | 0.7× | 6.3× | 1.4× | 1.4% | 0.1× | n/a |
| Alzai Health Corp. · TSXV:ALZI | US$11.86M | US$10.93M | n/a | 227× | n/a | 11.2× | n/a | 0.4× | n/a |
| Unipharma Co., Ltd. · TPEX:6621 | US$11.79M | US$8.53M | n/a | 3.2× | n/a | 2.0× | −45.8% | 0.0× | n/a |
| ImExHS Ltd · ASX:IME | US$11.16M | US$10.15M | n/a | 0.5× | 10.1× | 1.0× | −10.0% | 0.0× | n/a |
| Intrasense SA · EURONEXT:ALINS | US$11.00M | US$10.61M | n/a | 3.3× | n/a | n/a | −364.8% | n/a | n/a |
| iTonic Holdings Ltd · NASDAQ:ITOC | US$10.87M | US$8.90M | n/a | 17.0× | n/a | 0.5× | −974.7% | 0.0× | 1.06 |
| Republic Healthcare Limited · HKEX:8357 | US$10.83M | US$9.29M | n/a | 1.2× | n/a | 1.8× | −40.3% | 0.4× | n/a |
| Median of the others | US$11.83M | US$9.79M | 43.0× | 1.6× | 8.2× | 1.4× | −40.3% | 0.1× | 1.06 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (June 2013) | Shareholder meeting | 17 slides | Jun 20, 2013 |
Financials
Annual, in EUR
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 52.9M | 51.7M | 49.5M | 47.0M | 45.2M |
| Cost of revenue | 41.8M | 39.6M | 37.1M | 36.7M | 34.5M |
| Gross profit | 11.2M | 12.1M | 12.3M | 10.3M | 10.7M |
| Operating income | 5.40M | 5.06M | 5.21M | 3.85M | 4.54M |
| Depreciation and amortization | 2.99M | 2.52M | 1.99M | 6.47M | 6.13M |
| EBITDA | 8.39M | 7.58M | 7.20M | 10.3M | 10.7M |
| Income before tax | -80.0K | 418.0K | 1.28M | 1.02M | 1.38M |
| Income tax | 669.0K | 943.0K | 724.0K | 577.0K | 811.0K |
| Net income | -749.0K | -524.0K | 556.0K | 443.0K | 570.0K |
| Earnings per share, basic | -0.03 | -0.02 | 0.02 | 0.02 | 0.03 |
| Earnings per share, diluted | -0.03 | -0.02 | 0.02 | 0.02 | 0.03 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | 416.0K | 3.91M | 2.33M | 2.33M | 3.62M |
| Receivables | 4.82M | 5.51M | 4.53M | 3.78M | 3.94M |
| Inventory | 0 | 0 | 0 | ||
| Current assets | 7.74M | 11.1M | 8.91M | 12.3M | 13.6M |
| Property, plant and equipment | 102.1M | 98.8M | 41.8M | 37.0M | 34.8M |
| Goodwill | 20.2M | 20.2M | 18.7M | 18.5M | 18.5M |
| Total assets | 180.3M | 182.8M | 149.1M | 153.4M | 150.1M |
| Accounts payable | 7.23M | 6.45M | 6.17M | 5.50M | 5.95M |
| Current liabilities | 36.5M | 29.3M | 21.2M | 18.5M | 16.5M |
| Shareholders' equity | 29.1M | 29.8M | 29.9M | 29.4M | 28.8M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash from operations | 6.24M | 9.94M | 10.1M | 5.18M | 5.61M |
| Capital spending | -5.80M | -23.1M | -6.49M | -4.15M | -306.0K |
| Free cash flow | 436.0K | -13.1M | 3.59M | 1.03M | 5.31M |
| Cash from investing | -5.86M | -58.5M | -8.92M | -4.15M | -306.0K |
| Cash from financing | -3.87M | 50.1M | -2.45M | -4.79M | -562.0K |
| Change in cash | -3.49M | 1.58M | -1.29M | -3.76M | 4.75M |
Cap table
Built by 6ix from Eukedos SpA’s releases
- Common shares
- 22,741,628
- Fully diluted
- 22,741,628
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 22,741,628 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 22,741,628 |
Log in to ask 6ix AI your own questions about Eukedos SpA.